YOLFTbeta
BCWORLD PHARM. Co. Ltd

BCWORLD PHARM. Co. Ltd

200780 · KQ · Healthcare / Drug Manufacturers - General

2,800.00KRW-45.00 (-1.58%)

Price History

Full chart

Market Stats

Previous Close2,845.00
Open2,875.00
Day Range2,800.00 – 2,900.00
52-Week Range2,795.00 – 6,030.00
Volume8.11K
Market Cap30.56B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.33%
Beta0.71
50-Day Avg3,075.60
200-Day Avg4,139.69

About

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Sung-Han Hong
  • Employees289
  • Headquarters22 Geumto-ro 40beon-gil, Seongnam-si, South Korea, Korea
  • Websitehttps://www.bcwp.co.kr

Leadership

  • Mr. Sung-Han HongChief Executive Officer and President · b. 1957

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue41.41B45.66B50.21B55.11B51.73B56.93B62.08B72.70B75.11B74.81B75.80B
Growth (%)-+10.24%+9.96%+9.77%-6.13%+10.05%+9.04%+17.11%+3.31%-0.39%+1.32%
Cost of Revenue20.28B22.80B25.97B29.60B27.67B33.17B41.98B45.30B43.15B46.77B45.21B
Gross Profit21.14B22.86B24.24B25.51B24.07B23.76B20.10B27.40B31.96B28.05B30.59B
Gross Margin51.03%50.07%48.27%46.29%46.52%41.73%32.37%37.69%42.55%37.49%40.35%
Operating Expense14.62B15.95B15.36B16.23B17.49B20.48B21.63B25.61B25.60B26.55B28.59B
Operating Income6.52B6.91B8.87B9.28B6.57B3.28B-1.53B1.80B6.37B1.50B2.00B
Operating Margin15.73%15.14%17.67%16.84%12.70%5.75%-2.47%2.47%8.47%2.00%2.63%
EBITDA-------9.48B13.91B9.69B9.98B
EBITDA Margin-------13.04%18.52%12.95%13.16%
Net Income6.33B6.47B8.08B8.68B6.06B4.66B-1.84B281.30M2.63B-4.43B-4.90B
Net Income Margin15.28%14.18%16.10%15.74%11.71%8.19%-2.97%0.39%3.51%-5.92%-6.46%
R&D-6.56B6.65B7.24B7.26B9.31B9.17B8.37B6.14B7.78B8.99B
R&D as % of Total Revenue-14.36%13.24%13.14%14.03%16.35%14.77%11.51%8.18%10.40%11.86%
Interest Expense000002.40B2.07B3.79B5.23B4.76B4.24B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%4.22%3.33%5.22%6.97%6.36%5.59%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets79.36B96.42B118.34B161.74B172.78B192.96B179.36B183.05B184.11B176.31B176.80B
Total Liabilities11.96B22.54B37.11B71.65B75.53B91.27B97.90B103.50B102.47B99.65B104.30B
Total Equity67.40B73.88B81.23B90.09B97.24B101.69B81.46B79.55B81.64B76.67B71.28B
Cash4.25B1.22B3.84B2.39B1.69B10.68B2.17M1.11M600.00K800.00K5.88B
Total Debt-11.76B24.01B45.78B47.99B59.25B-----
Net Debt-----65.63B86.07B90.00B84.22B82.73B80.37B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.78B243.66M7.90B5.34B12.11B-5.50B-619.83M6.88B10.94B4.04B5.58B
Investing Cash Flow-26.13B-12.80B-19.35B-31.34B-20.61B-8.11B-17.69B-6.68B-3.76B-1.14B-
Financing Cash Flow-3.47B9.52B14.09B24.54B7.77B22.92B10.34B1.07B-4.25B-4.52B-
Capital Expenditure25.26B12.56B16.58B29.92B21.32B7.79B17.44B6.22B2.71B2.41B4.01B
Free Cash Flow------13.80B-19.89B444.44M8.23B1.63B1.57B
Dividends Paid635.51M641.74M641.74M705.19M775.33M771.83M853.86M853.86M542.73M542.73M542.73M
FCF to OCF-----250.84%3209.31%6.46%75.23%40.43%28.19%
Dividend Paid to FCF------5.59%-4.29%192.12%6.60%33.21%34.53%

Earnings

Report DateMay 13, 2015Jul 31, 2015Oct 26, 2015Feb 11, 2016May 9, 2016Aug 1, 2016Oct 24, 2016Feb 12, 2017Apr 20, 2017Jul 31, 2017Oct 31, 2017Feb 6, 2018May 3, 2018Jul 24, 2018Oct 28, 2018Feb 17, 2019May 9, 2019Jul 28, 2019Nov 13, 2019Feb 28, 2020May 14, 2020Aug 10, 2020Nov 13, 2020Feb 3, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------
EPS Actual144.45216.79195.22184.23171.18223.37216.97165.30256.23231.98263.96222.31222.84247.70222.69-104.69227.19216.31252.65-884.55410.00283.00126.00-39.57109.05140.9882.91-35.7354.0527.31-14.19-40.4322.03569.568.55-342.19-151.74-190.07-106.8314.54-220.32-73.00-108.83-105.8332.57-110.96
Surprise----------------------------------------------
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hoursPre-marketAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hours----------------------

Key Statistics & Ratios

Market Cap30.56B
Enterprise Value101.80B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.38
Price / Book0.44
Revenue (TTM)80.33B
Gross Profit (TTM)30.48B
EBITDA11.03B
Profit Margin-3.61%
Operating Margin0.70%
Return on Equity-1.75%
Return on Assets1.01%
Shares Outstanding10.22M
Shares Float5.87M
Beta0.71
Dividend Yield3.33%
Dividend Rate100.00
Payout Ratio99.01%

Dividends

20251×
100.00Dec 29, 2025
20241×
90.91Dec 27, 2024
20231×
82.64Dec 27, 2023
20221×
82.64Dec 28, 2022
20211×
82.64Dec 29, 2021
20201×
82.64Dec 29, 2020
20191×
82.64Dec 27, 2019
20181×
75.13Dec 27, 2018
20171×
75.13Dec 27, 2017
20161×
68.30Dec 28, 2016
20141×
62.09Dec 29, 2014

Stock Splits

  • Dec 29, 202511:10
  • Dec 27, 202411:10
  • Dec 27, 201911:10
  • Dec 27, 201711:10
  • Dec 28, 201611:10